Drug Shortage Report for ADENOSINE INJECTION
| Report ID | 159829 |
| Drug Identification Number | 02267659 |
| Brand name | ADENOSINE INJECTION |
| Common or Proper name | ADENOSINE INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ADENOSINE |
| Strength(s) | 3MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 2ML |
| ATC code | C01EB |
| ATC description | OTHER CARDIAC PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-06-01 |
| Estimated end date | 2022-06-24 |
| Actual end date | 2022-06-24 |
| Shortage status | Resolved |
| Updated date | 2022-06-27 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to a shipping delay, we will be encountering a supply interruption on our Adenosine 3 mg/mL SD Vial 2 mL effective June 1, 2022 until June 24, 2022. During this time, allocations for our Adenosine Injection 3 mg/mL prefilled syringe 2 mL will be increased. Contract customers will be allocated 100% of historical 2 mL syringe demand plus 100% of 2 mL vial demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2022-06-27 | French | Compare |
| v9 | 2022-06-27 | English | Compare |
| v8 | 2022-06-02 | English | Compare |
| v7 | 2022-05-24 | French | Compare |
| v6 | 2022-05-24 | English | Compare |
| v5 | 2022-05-24 | French | Compare |
| v4 | 2022-05-24 | English | Compare |
| v3 | 2022-05-03 | English | Compare |
| v2 | 2022-05-02 | French | Compare |
| v1 | 2022-05-02 | English | Compare |
Showing 1 to 10 of 10